Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth D Tew

Showing results (11-20 of 114) with videos related to

Pageof 12
Sort By:
Expert Opinion on Investigational Drugs|July 30, 2005
TLK-286: a novel glutathione S-transferase-activated prodrugKenneth D Tew
Advances in Cancer Research|August 6, 2021
Reductive stress in cancerLeilei Zhang, Kenneth D Tew
Expert Opinion on Therapeutic Targets|January 24, 2003
Glutathione S-transferases as emerging therapeutic targetsLaurent Gaté, Kenneth D Tew
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 4, 2003
Trace elements in human physiology and pathology: zinc and metallothioneinsHaim Tapiero, Kenneth D Tew
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 16, 2001
GST function in drug and stress responseKenneth D. Tew, Ze'ev Ronai
Advances in Cancer Research|October 22, 2017
PrefaceKenneth D Tew, Francesco Galli
Biochemical Pharmacology|December 11, 2017
ATP-binding cassette transporter-2 (ABCA2) as a therapeutic targetWarren Davis, Kenneth D Tew
Current Opinion in Chemical Biology|November 16, 2010
Redox platforms in cancer drug discovery and developmentKenneth D Tew, Danyelle M Townsend
Oncogene|October 25, 2003
The role of glutathione-S-transferase in anti-cancer drug resistanceDanyelle M Townsend, Kenneth D Tew
Methods in Molecular Biology (Clifton, N.J.)|February 19, 2004
Amplified differential gene expression microarrayZhijian J Chen, Kenneth D Tew
Pageof 12

Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
Expert Opinion on Investigational Drugs|July 30, 2005
TLK-286: a novel glutathione S-transferase-activated prodrugKenneth D Tew
Advances in Cancer Research|August 6, 2021
Reductive stress in cancerLeilei Zhang, Kenneth D Tew
Expert Opinion on Therapeutic Targets|January 24, 2003
Glutathione S-transferases as emerging therapeutic targetsLaurent Gaté, Kenneth D Tew
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 4, 2003
Trace elements in human physiology and pathology: zinc and metallothioneinsHaim Tapiero, Kenneth D Tew
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 16, 2001
GST function in drug and stress responseKenneth D. Tew, Ze'ev Ronai
Advances in Cancer Research|October 22, 2017
PrefaceKenneth D Tew, Francesco Galli
Biochemical Pharmacology|December 11, 2017
ATP-binding cassette transporter-2 (ABCA2) as a therapeutic targetWarren Davis, Kenneth D Tew
Current Opinion in Chemical Biology|November 16, 2010
Redox platforms in cancer drug discovery and developmentKenneth D Tew, Danyelle M Townsend
Oncogene|October 25, 2003
The role of glutathione-S-transferase in anti-cancer drug resistanceDanyelle M Townsend, Kenneth D Tew
Methods in Molecular Biology (Clifton, N.J.)|February 19, 2004
Amplified differential gene expression microarrayZhijian J Chen, Kenneth D Tew
Pageof 12